You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Atypical response with bone pseudoprogression in a patient receiving nivolumab for advanced cutaneous squamous cell carcinoma

Article metrics

Article menu

Download PDFPDF

Case Report
Atypical response with bone pseudoprogression in a patient receiving nivolumab for advanced cutaneous squamous cell carcinoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2025

AbstractFullPdf
Dec 2019330
Jan 2020660
Feb 202014142
Mar 202014141
Apr 202024240
May 202026261
Jun 202021213
Jul 202030302
Aug 2020994
Sep 202036367
Oct 202025253
Nov 202018181
Dec 202016161
Jan 202111115
Feb 202116162
Mar 202126266
Apr 202117173
May 202112123
Jun 202118180
Jul 2021881
Aug 2021991
Sep 202110102
Oct 2021454531
Nov 2021141411
Dec 202114142
Jan 202216174
Feb 202213133
Mar 202212125
Apr 202213143
May 202228289
Jun 202220208
Jul 202214152
Aug 202228286
Sep 202221218
Oct 202217176
Nov 2022141616
Dec 202215151
Jan 202312124
Feb 202328282
Mar 202315164
Apr 202313134
May 2023995
Jun 202312125
Jul 2023779
Aug 202314147
Sep 2023995
Oct 2023666
Nov 202311112
Dec 202314143
Jan 202411122
Feb 202412124
Mar 202412124
Apr 202421215
May 2024773
Jun 2024201910
Jul 202429306
Aug 202428252
Sep 202413137
Oct 202414147
Nov 202429313
Dec 202411128
Jan 2025151517
Feb 202558582
Mar 202523235
Total11061113304